The case for lamotrigine monitoring in pregnancy

Journal of Clinical Neuroscience

Volumn 13, Issue 1, 2006, Pages 103-104

  Vajda, F ^a,b   Solinas, C ^a   Graham, J ^a   Hitchcock, A ^a   Eadie, M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; PHENYTOIN; VALPROIC ACID;

ARTICLE; BIPOLAR DISORDER; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; NEUROTOXICITY; PREGNANCY; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT; TERATOGENICITY;

ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; MONITORING, PHYSIOLOGIC; PREGNANCY; TRIAZINES;

EID: 30344449170     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2005.04.009     Document Type: Article

References (9)

1. M.C. Walker, and J.W. Sander Lamotrigine M.J. Eadie F.J.E. Vajda Handbook of experimental pharmacology 1999 Springer Heidelberg 331 358
2. A. Bartoli, R. Guerrini, A. Belmonte, N.G. Alessandri, G. Gatti, and E. Pecucca The influence of dosage, age and comedication on steady state plasma lamotrigine concentrations in children: a prospectice study with preliminary assessment of correlation and clinical response Ther Drug Monit 19 1997 252 260
3. P.N. Patsalos, and E. Perucca Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs Lancet Neurol 2 2003 347 356
4. P.N. Patsalos, W. Froscher, F. Pisani, and C.M. van Rijn The importance of drug interactions in epilepsy therapy Epilepsia 43 2002 365 385
5. Vajda FJE, Hitchcock A, Graham J, et al. Foetal malformations and seizure control; 52 months data of the Australian Pregnancy Registry. Submitted to Neurology (Feb. 2005).
6. T.A. Tran, I.E. Leppik, K. Blesi, S.T. Sathananandan, and R. Remmel Lamotrigine clearence during pregnancy Neurology 59 2002 25 251
7. A. Sabers, J.M. Buchholt, P. Uldall, and E.L. Hansen Lamotrigine plasma levels reduced by oral contraceptives Epilepsy Res 47 2001 151 154
8. G.J. de Haan, P. Edelbroek, and J. Segers Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study Neurology 63 2004 571 573
9. A. Sabers, I. Ohman, J. Christensen, and T. Tomson Oral contraceptives reduce lamotrigine plasma levels Neurology 61 2003 570 571